Document:

EXHIBIT 10.1

                              EMPLOYMENT AGREEMENT

      This EMPLOYMENT AGREEMENT ("Agreement") is made and entered into as of
this 16th day of June 2005, by and between the Berman Center, Inc., a Delaware
corporation ("Company" or "Berman Center"), and Laura A.C. Berman, LCSW, Ph.D.,
an individual ("Dr. Berman"). Company or Dr. Berman are sometimes referred to
herein as "party" or collectively as "parties".

                                    RECITALS

      WHEREAS, Dr. Berman, a sex educator and therapist, is co-founder of the
Berman Center, a specialized health center for women focusing on female sexual
health and menopause management; and

      WHEREAS, Company recognizes that Dr. Berman's talents and abilities are
unique, and have been integral to the success of the Berman Center, and thus
wishes to secure the ongoing services of Dr. Berman; and

      WHEREAS, Company is currently involved in a reverse merger transaction
(the "Merger", as defined in the Placement Agent Agreement by and between
Company and Hunter World Markets dated April 11, 2005); and

      WHEREAS, the Merger shall be completed on June 16, 2005 (the "Effective
Date"); and

      WHEREAS, following the completion of the Merger, Company wishes to engage
the services of Dr. Berman under the terms and conditions stated herein as of
the Effective Date;

      NOW, THEREFORE, in consideration of the mutual covenants and agreements
hereinafter contained, and for other good and valuable consideration, it is
hereby agreed by and between the parties hereto as follows:

1.    Term

      The term of employment under this Agreement shall be for a period
commencing on the Effective Date and concluding on the third anniversary of the
Effective Date (the "Term", inclusive of any and all extensions, if applicable),
unless terminated earlier pursuant to the provisions of Paragraph 7 below. At or
near the expiration of the Term, the parties agree to engage in good faith
discussions regarding a new employment contract or an extension of this
Agreement. However, neither party shall be obligated to enter into a new
agreement, nor does this Paragraph 1 create any representation, express or
implied, that a new agreement will be entered into.

2.    Employment and Duties

      (a) Employment. Company hereby employs Dr. Berman as the President and
Executive Director of Company and Dr. Berman hereby accepts such employment as
of the Effective Date pursuant to the terms, covenants and conditions set forth
herein. Dr. Berman shall report directly to the Board of Directors of Company.
<PAGE>

      (b) Exclusivity. During the Term, Dr. Berman shall render her services
exclusively to Company.

      (c) Services. During the Term, Dr. Berman shall render services to Company
to the best of her ability and in a manner satisfactory to Company. Dr. Berman
shall be responsible for rendering services to Company that include, without
limitation, the following:

            (i) Dr. Berman shall render all services customarily rendered by
individuals in similar capacities with companies that provide sexual health
services to women, or which duties are delegated to her by the Board of
Directors consistent with such positions and/or the terms of this Agreement.

            (ii) In connection with any and all media, whether now known or
hereafter created, including without limitation, television, film, radio, DVD,
CD, CD-ROM, Internet, and live stage, Dr. Berman shall render services in the
capacity of, including without limitation, performer, host, co-host, expert,
consultant, producer, executive producer, writer, teacher, lecturer, and
endorser of products and services in areas of businesses of Company covered
under this Agreement (the services defined in Paragraph 2(c)(i) and (ii) shall
be collectively referred to as the "Services"). The foregoing notwithstanding,
Dr. Berman's services rendered prior to the Effective Date of this Agreement
including, without limitation, Dr. Berman's services as co-host of the
television program, "Berman and Berman: For Women Only," on the Discovery Health
Channel as well as Dr. Berman's services as host of the syndicated radio talk
show, "The Dr. Laura Berman Show" (collectively, the "Prior Services") shall be
deemed Services rendered hereunder.

            (iii) If Dr. Berman creates, individually and/or jointly with third
parties, products pursuant to this Agreement in connection with the Services
rendered hereunder, such products shall include, without limitation, Dr.
Berman's authorship and co-authorship of books, articles, essays, manuals,
scripts or other literary products, Dr. Berman's creation of medical and
treatment devices, wellness, nutritional and exercise programs, and any and all
other products created by Dr. Berman in areas of businesses of Company covered
under this Agreement (the "Products"). The foregoing notwithstanding, products
created by Dr. Berman prior to the Effective Date of this Agreement including,
without limitation, Dr. Berman's best selling books, "For Women Only: A
Revolutionary Guide to Overcoming Sexual Dysfunction and Reclaiming Your Sex
Life (Henry Holt, 2000), "Secrets of the Sexually Satisfied Woman" (Hyperion
Books, ___) and "The Passion Prescription: Ten Weeks to Your Best Sex Ever"
(Hyperion Books, ___) (collectively, the "Prior Products") shall be deemed
Products created hereunder. For clarification purposes, if Dr. Berman co-created
any Product, this Agreement only applies to such portion that was created by or
attributable to Dr. Berman.

      (d) Time and Efforts. Dr. Berman shall devote her full-time efforts,
attention, and energies to the business of the Company.

                                       2
<PAGE>

      (e) Place of Performance. During the Term, Company shall maintain
executive offices for Dr. Berman in Chicago, IL, and Dr. Berman shall not be
required to relocate to any other location. Subject to Dr. Berman's prior
approval, Company shall provide Dr. Berman with an exclusive office, private
secretary, usual and customary office support and staff consistent with the
practices of Company and as is customary in the health care industry.

3.    Compensation

      (a) Salary. As the total consideration for Dr. Berman's Services rendered
and Products created hereunder, Dr. Berman shall be entitled to an annual salary
of Two Hundred Thousand Dollars ($200,000.00) (the "Salary") beginning on the
Effective Date of the Agreement and payable in regular installments in
accordance with the customary payroll practices of Company. The Salary may be
increased at the discretion of the Board of Directors on or after the 180th day
following the Effective Date. The Salary shall not be decreased.

      (b) Expenses. During the Term, Company shall pay or promptly reimburse Dr.
Berman for all business, travel and entertainment expenses consistent with Dr.
Berman's title and the practices of Company in effect during the Term,
including, without limitation, business class air transportation, standard room
at first class hotel, exclusive ground transportation by town car, when
necessary, otherwise taxis to and from airports, first class luxury rental car
or car service at Dr. Berman's discretion, car lease allowance of $1200/month,
inclusive of insurance and gas expenses but exclusive of maintenance expenses.
Company shall also provide Dr. Berman with any and all items reasonably
necessary and appropriate to render the Services and create the Products
hereunder to the best of her abilities including, without limitation, electronic
equipment and a personal assistant for use during the Term.

      (c) Vacation. Dr. Berman shall be entitled to six (6) weeks of vacation
per year. Vacation not taken during the applicable fiscal year (but in excess of
three weeks) shall be carried over to the next following fiscal year.

      (d) Welfare, Pension and Incentive Benefit Plans. During the Term, Dr.
Berman (and her eligible spouse and dependents) shall be entitled to participate
in all the welfare benefit plans and programs maintained by Company from time to
time for the benefit of its senior executives including, without limitation, all
medical (medical insurance shall be at least POS or PPD with a deductible not
greater than $250/person), hospitalization, dental, disability, accidental death
(accidental death insurance in an amount not less than $2,000,000.00) and
dismemberment and travel accident insurance plans and programs. In addition,
during the Term, Dr. Berman shall be eligible to participate in all pension,
retirement, savings and other employee benefit plans and programs maintained
from time to time by Company for the benefit of its senior executives, other
than any annual cash incentive plan.

      (e) Dues. During the Term, Company shall pay or promptly reimburse Dr.
Berman for annual dues for membership in organizations including, but not
limited to, the American Federation of Television and Radio Artists, the Screen
Actors Guild, medical and health associations.

                                       3
<PAGE>

4.    Revenues

      (a) Any and all net revenues generated as a result of Dr. Berman's
Products created hereunder, to the extent such revenues are payable to Dr.
Berman, shall be payable to Company in perpetuity when any such revenues are
received by Dr. Berman or on Dr. Berman's behalf, directly or indirectly, or by
any person, firm or corporation on Dr. Berman's behalf pursuant to contracts,
engagements and commitments entered into during the Term. In connection with the
foregoing: (i) all agreements substantially negotiated during the Term and
executed within six (6) months thereafter shall be deemed entered into during
the Term and (ii) Company shall be entitled to any and all revenues in
perpetuity with respect to Products created by Dr. Berman during the Term
pursuant to agreements entered into during the Term. For the avoidance of doubt,
any and all revenues accruing and received after the commencement of the Term
which are generated as a result of Prior Products created, to the extent such
revenues are payable to Dr. Berman, shall be automatically paid to Company.

      (b) Any and all net revenues generated as a result of Dr. Berman's
Services rendered hereunder, to the extent such revenues are payable to Dr.
Berman, shall be payable to Company in perpetuity when any such revenues are
received by Dr. Berman or on Dr. Berman's behalf, directly or indirectly, or by
any person, firm or corporation on Dr. Berman's behalf pursuant to contracts,
engagements and commitments entered into during the Term. For the avoidance of
doubt, any and all revenues accruing and received after the commencement of the
Term which are generated as a result of Prior Services rendered, to the extent
such revenues are payable to Dr. Berman, shall be automatically paid to Company.
Notwithstanding the foregoing, Dr. Berman shall not be required to pay or
contribute to Company any income, revenue or other compensation derived from
honorarium fees and live speaking engagements. If, after the expiration of the
Term of this Agreement, Dr. Berman renders Services pursuant to an agreement
entered into during the Term of this Agreement, Company shall not be entitled to
any revenues earned after the expiration of the Term.

      (c) In the event Dr. Berman's employment is terminated pursuant to
Paragraphs 6(b) or 6(d) herein, any and all revenues generated as a result of
Dr. Berman's Services rendered and Products created hereunder shall be
immediately payable to Dr. Berman.

5.    Agreements

      (a) During the Term, Company may enter into third party agreements for Dr.
Berman's Services rendered and Products created hereunder. In the event that Dr.
Berman enters into any such third party agreement(s) directly, Dr. Berman agrees
and acknowledges that any and all revenues generated as a result of such third
party agreement(s) shall be automatically assignable to Company, and the terms
and conditions of this Agreement shall govern.

      (b) If the term of any third party agreement extends beyond the Term of
this Agreement and Dr. Berman's employment is not terminated pursuant to
Paragraphs 6(b) or 6(d) herein, Dr. Berman shall continue to create Products
pursuant to such third party agreement until the termination or expiration
thereof and any and all revenues generated as a result of such third party
agreement shall be automatically assignable to Company for the length of the
term of such third party agreement, and the terms and conditions of this
Agreement shall govern.

                                       4
<PAGE>

      (c) If the term of any third party agreement extends beyond the Term of
this Agreement and Dr. Berman's employment is not terminated pursuant to
Paragraphs 6(b) or 6(d) herein, Dr. Berman shall continue to render Services
pursuant to such third party agreement until the termination or expiration
thereof provided that any and all revenues generated as a result of such third
party agreement shall be payable to Dr. Berman and the terms and conditions of
this Agreement shall not govern.

6.    Termination

      Dr. Berman's employment shall terminate upon the happening of the
following:

      (a) Termination For Cause. Company may terminate this Agreement for Cause
if the Board of Directors determines that Cause exists provided, however, that
such termination for Cause requires a resolution approved by seventy-five
percent (75%) of the Board of Directors. There shall also be a special meeting
of the Board of Director after written notification to Dr. Berman that in the
good faith opinion of the Board of Directors, Dr. Berman is guilty of the
misconduct described herein with particular detail. Thereafter, Dr. Berman shall
be given an opportunity to meet with the Board of Directors to discuss and
attempt to cure the misconduct. For purposes of this Agreement, "Cause" shall
mean

            (i) A proven act of dishonesty, fraud, embezzlement, or
misappropriation of proprietary information in connection with the Dr. Berman's
responsibilities as President and Director of the Berman Center;

            (ii) Dr. Berman's conviction of, or plea of nolo contendere to, a
felony or a crime involving moral turpitude; or

            (iii) Dr. Berman's habitual failure or refusal to perform her
employment duties under this Agreement if such failure or refusal is not cured
by Dr. Berman within thirty (30) days after receiving written notice thereof
from the Board of Directors.

      (b) Termination Without Cause.

            (i) Company may terminate this Agreement Without Cause. For purposes
of this Agreement, "Without Cause" shall mean termination by Company of Dr.
Berman's employment for any reason, including termination from a Change of
Control (as defined herein), other than as specified in Paragraphs 6(a) and 6(c)
hereof.

            (ii) Change of Control shall mean the occurrence of any one of the
following: (i) any "person," as such term is used in Sections 13(d) and 14(d) of
the Securities Exchange Act of 1934, as amended (the "Exchange Act") (other than
Company, a subsidiary, an affiliate, or a Company employee benefit plan,
including any trustee of such plan acting as trustee) becoming the "beneficial
owner" (as defined in Rule 13d-3 under the Exchange Act), directly or
indirectly, of securities of Company representing 50% or more of the combined
voting power of Company's then outstanding securities; (ii) a sale of assets
involving 50% or more of the fair market value of the assets of Company as
determined in good faith by the Board of Directors of Company; or (iii) any
merger or reorganization of Company whether or not another entity is the
survivor, pursuant to which the holders of all the shares of capital stock of
Company outstanding prior to the transaction hold, as a group, fewer than 50% of
the shares of capital stock of Company outstanding after the transaction.

                                       5
<PAGE>

            (iii) Company may terminate the employment of Dr. Berman and all of
Company's obligations hereunder (except as hereinafter provided) at any time
during the Term of this Agreement "Without Cause" by giving Dr. Berman written
notice of such termination, to be effective thirty (30) days following the
giving of such written notice.

      (c) Termination Due to Disability or Death. Dr. Berman's employment
hereunder may be terminated by Company as follows:

            (i) To the extent permitted by law, upon thirty (30) days' prior
written notice to Dr. Berman in the event that Dr. Berman has been unable to
perform substantially all of her duties under this Agreement for an aggregate of
150 days (inclusive of weekends and holidays) within any 12-month period, as the
result of Dr. Berman's incapacity to perform the essential functions of her job
due to a physical or mental disability and after reasonable accommodation made
by Company, and within thirty (30) days of receipt of such notice, Dr. Berman
shall not have returned to the full-time, continuing performance of her duties
hereunder, or

            (ii) Immediately upon the death of Dr. Berman.

      (d) Termination for Good Reason. Dr. Berman may terminate the Agreement
for "Good Reason". Dr. Berman's termination shall be for "Good Reason" if Dr.
Berman provides written notice to Company of the Good Reason within six (6)
months of the event constituting Good Reason, or as soon as the event becomes
known to Dr. Berman, whichever is later, and provides Company with a period of
thirty (30) days to cure the Good Reason and Company fails to cure the Good
Reason within that period. For purposes of this Agreement, "Good Reason" shall
mean any of the following events if the event is effected by Company or third
parties without Dr. Berman's consent: (i) a reduction in the Salary or other
component of compensation and benefits, except for changes to Company's
generally applicable benefit plans and policies; or (ii) if Company then changes
Dr. Berman's title, position, reporting or job duties which materially reduces
Dr. Berman's level of responsibility, (except for any reduction for Cause as
defined above). Dr. Berman may terminate her employment at any time for Good
Reason, in which case Dr. Berman shall receive the compensation and benefit
continuation required by Paragraph 7(c) below. The foregoing notwithstanding,
Dr. Berman shall have the right to terminate this Agreement without Good Reason
by providing Company with written notice thereof.

      (e) Voluntary Termination. Dr. Berman's employment hereunder may be
terminated by Dr. Berman for any reason (other than by Termination Due to
Disability or Death) upon Dr. Berman providing Company with thirty (30) days'
notice of Dr. Berman's voluntary termination.

7.    Effect of Termination

      (a) Termination For Cause or Voluntary Termination. In the event that Dr.
Berman's employment is terminated pursuant to Paragraphs 6(a) or 6(e) above:

                                       6
<PAGE>

            (i) Company shall pay to Dr. Berman, or her representatives, on the
date of termination of employment (the "Termination Date") only that portion of
the Salary provided in Paragraph 3(a) that has been earned to the Termination
Date, and any accrued but unpaid Vacation pay provided in Paragraph 3(c), and
any expense reimbursements due and owing to Dr. Berman as of the Termination
Date.

      (b) Termination Due to Disability or Death. In the event Dr. Berman's
employment is terminated pursuant to Paragraph 6(c) above, Company shall pay to
Dr. Berman, or her representatives, on the Termination Date the following:

            (i) The payments, if any, referred to in Paragraph 7(a)(i) above.

      (c) Termination Without Cause or for Good Reason. In the event Dr.
Berman's employment is terminated pursuant to Paragraphs 6(b) or 6(d) above,
Company shall pay Dr. Berman all of the following:

            (i) The payments referred to in Paragraph 7(a)(i) above; and

            (ii) Dr. Berman's salary for the remainder of the Term hereof.

            (iii) Upon Dr. Berman's Termination Without Cause or Termination for
Good Reason, any and all rights in and to the Services rendered and Products
created hereunder including, without limitation, all right, title, interest, and
license (including the Property license as granted pursuant to the Intellectual
Property License and Preservation Agreement entered into by and between the
parties dated as the date hereof) and in the Services and Products, shall
immediately vest in and revert back to Dr. Berman and the provisions of
Paragraphs 9 and 10 of this Agreement shall not apply. In connection therewith,
Company agrees to execute such any and all documents and instruments as may
reasonably be required in order to effectuate the terms and intentions of this
Paragraph 7(c)(iii), and in the event Company fails or is unable to execute any
such documents or instruments, after receipt of a written request therefore from
Dr. Berman, Company hereby appoints Dr. Berman as its irrevocable attorney in
fact to execute any such documents or instruments, provided that said documents
and instruments shall not be inconsistent with the terms and conditions of this
Agreement. Dr. Berman's rights under this Paragraph 7(c)(iii) constitute a power
coupled with an interest and are irrevocable.

8.    Confidential Information

      Except as may be required or appropriate in connection with her carrying
out her duties under this Agreement, Dr. Berman shall not, without the prior
written consent of Company or as may be required by law or any legal process, or
as is necessary in connection with any adversarial proceeding against Company
(in which case Dr. Berman shall cooperate with Company in obtaining a protective
order at Company's expense against disclosure by a court of competent
jurisdiction), communicate, to anyone other than Company in the furtherance of
its business or to perform her duties hereunder, any trade secrets, confidential
information, knowledge or data relating to Company and its businesses and
investments, obtained by Dr. Berman during the Term by Company and that is not
generally available public knowledge.

                                       7
<PAGE>

9.    Noncompetition

      (a) During the Term, and for twelve (12) months after the Termination Date
if Dr. Berman is terminated by Company for Cause or Dr. Berman terminates
without Good Reason, Dr. Berman shall not engage in or become associated with
any Competitive Activity. For purposes of this Paragraph 9, a "Competitive
Activity" shall mean any business or other endeavor that engages in any United
States territory in which Company has significant business operations as of the
Date of Termination to a significant degree in a business that directly competes
with all or any substantial part of Company's business of using Dr. Berman's
name, likeness, image, or voice to the extent such uses involve counseling and
core businesses of Dr. Berman, excluding television appearances and book
publishing, in connection with any Services rendered or Products created
hereunder (the "Business"); provided, that, a Competitive Activity shall not
include (i) any speaking engagement to the extent such speaking engagement does
not promote or endorse a product or service of the Business, (ii) the writing of
any book or article relating to subjects other than the Business (e.g.,
nonfiction relating to Dr. Berman's career or general business advice) or (iii)
the television, video or movie business so long as such business does not relate
to the Business. Dr. Berman shall be considered to have become "associated with
a Competitive Activity" if she becomes involved as an owner, employee, officer,
director, independent contractor, agent, partner, advisor, or in any other
capacity calling for the rendition of Dr. Berman's personal services, with any
individual, partnership, corporation or other organization that is engaged in a
Competitive Activity and her involvement relates to a significant extent to the
Competitive Activity of such entity; provided, however, that Dr. Berman shall
not be prohibited from (a) owning less than one percent (1%) of any publicly
traded corporation, whether or not such corporation is in competition with
Company or (b) serving as a director of a corporation or other entity the
primary business of which is not a Competitive Activity. If, at any time, the
provisions of this Paragraph 10 shall be determined to be invalid or
unenforceable, by reason of being vague or unreasonable as to area, duration or
scope of activity, this Paragraph 10 shall be considered divisible and shall
become and be immediately amended to only such area, duration and scope of
activity as shall be determined to be reasonable and enforceable by the court or
other body having jurisdiction over the matter; and Dr. Berman agrees that this
Paragraph 9 as so amended shall be valid and binding as though any invalid or
unenforceable provision had not been included herein.

      (b) In the event Dr. Berman engages in or becomes associated with any
Competitive Activity during the Term, any and all revenues generated as a result
of Dr. Berman's involvement in such Competitive Activity shall be automatically
assignable to Company.

      (c) In the event Dr. Berman is terminated Without Cause or Dr. Berman
terminates for Good Reason, the provisions of Paragraph 9(a) and 9(b) shall not
apply.

10.   Nonsolicitation

      (a) During the Term, and for twelve (12) months after the Termination Date
if Dr. Berman is terminated by Company for Cause or Dr. Berman terminates
without Good Reason, Dr. Berman will not, directly or indirectly, solicit for
employment any person (other than any personal secretary or assistant hired to
work directly for Dr. Berman) employed by Company or its affiliated companies,
nor will Dr. Berman, directly or indirectly, solicit for employment any person
known by Dr. Berman (after reasonable inquiry) to be employed at the time by
Company or its affiliated companies.

                                       8
<PAGE>

      (b) In the event Dr. Berman is terminated Without Cause or Dr. Berman
terminates for Good Reason, the provisions of Paragraph 10(a) shall not apply.

11.   Approvals

      Dr. Berman shall have the right to approve all uses of her name, likeness,
biography and any and all statements attributed to her, which approval shall not
be unreasonably withheld and shall be given to Company within five (5) business
days after such materials are submitted by Company to Dr. Berman. Dr. Berman's
failure to give such notice as aforesaid shall be deemed to be Dr. Berman's
disapproval as to the material for which such approval is sought. All materials
submitted by Dr. Berman to Company shall be deemed approved by Dr. Berman.

12.   Indemnification

      (a) General. Company agrees that if Dr. Berman is made a party or is
threatened to be made a party to any action, suit or proceeding, whether civil,
criminal, administrative or investigative (a "Proceeding"), by reason of the
fact that Dr. Berman is or was a trustee, director or officer of Company, or any
predecessor to Company (including any sole proprietorship owned by Dr. Berman)
or any of their affiliates or is or was serving at the request of Company, any
predecessor to Company (including any sole proprietorship owned by Dr. Berman),
or any of their affiliates as a trustee, director, officer, member, employee or
agent of another corporation or a partnership, joint venture, limited liability
company, trust or other enterprise, including, without limitation, service with
respect to employee benefit plans, whether or not the basis of such Proceeding
is alleged action in an official capacity as a trustee, director, officer,
member, employee or agent while serving as a trustee, director, officer, member,
employee or agent, or in connection with any of the Services rendered or
Products created hereunder, Dr. Berman shall be defended, indemnified and held
harmless by Company to the fullest extent authorized by California law, as the
same exists or may hereafter be amended, against all Expenses incurred or
suffered by Dr. Berman in connection therewith, and such indemnification shall
continue as to Dr. Berman even if she has ceased to be an officer, director,
trustee or agent, or is no longer employed by Company and shall inure to the
benefit of her heirs, executors and administrators.

      (b) Expenses. As used in this Agreement, the term "Expenses" shall
include, without limitation, damages, losses, judgments, liabilities, fines,
penalties, excise taxes, settlements, and costs, attorneys' fees, accountants'
fees, and disbursements and costs of attachment or similar bonds,
investigations, and any expenses of establishing a right to indemnification
under this Agreement.

      (c) Enforcement. If a claim or request under this Paragraph 12 is not paid
by Company or on its behalf, within thirty (30) days after a written claim or
request has been received by Company, Dr. Berman may at any time thereafter
bring suit against Company to recover the unpaid amount of the claim or request
and if successful in whole or in part, Dr. Berman shall be entitled to be paid
also the expenses of prosecuting such suit against Company. All obligations for
indemnification hereunder shall be subject to, and paid in accordance with,
applicable California law.

                                       9
<PAGE>

      (d) Partial Indemnification. If Dr. Berman is entitled under any provision
of this Agreement to indemnification by Company for some or a portion of any
Expenses, but not, however, for the total amount thereof, the Company shall
nevertheless indemnify Dr. Berman for the portion of such Expenses to which Dr.
Berman is entitled.

      (e) Advances of Expenses. Expenses incurred by Dr. Berman in connection
with any Proceeding shall be paid by Company in advance upon request of Dr.
Berman that Company pay such Expenses, but only in the event that Dr. Berman
shall have delivered in writing to Company (i) an undertaking to reimburse
Company for Expenses with respect to which Dr. Berman is not entitled to
indemnification and (ii) a statement of her good faith belief that the standard
of conduct necessary for indemnification by Company has been met.

      (f) Notice of Claim. Dr. Berman shall give to Company notice of any claim
made against her for which indemnification will or could be sought under this
Agreement. In addition, Dr. Berman shall give Company such information and
cooperation as it may reasonably require and as shall be within Dr. Berman's
power and at such times and places as are convenient for Dr. Berman.

      (g) Defense of Claim. With respect to any Proceeding as to which Dr.
Berman notifies Company of the commencement thereof:

            (i) Company will be entitled to participate therein at its own
expense;

            (ii) Except as otherwise provided below, to the extent that it may
wish, Company will be entitled to assume the defense thereof, with counsel
reasonably satisfactory to Dr. Berman, which in Company's sole discretion may be
regular counsel to Company and may be counsel to other officers and directors of
Company or any subsidiary. Dr. Berman also shall have the right to employ her
own counsel in such action, suit or proceeding if she reasonably concludes that
failure to do so would involve a conflict of interest between Company and Dr.
Berman, and under such circumstances the fees and expenses of such counsel shall
be at the expense of Company.

            (iii) Company shall not be liable to indemnify Dr. Berman under this
Agreement for any amounts paid in settlement of any action or claim affected
without its written consent. Company shall not settle any action or claim in any
manner which would impose any penalty that would not be paid directly or
indirectly by Company or limitation on Dr. Berman without Dr. Berman's written
consent. Neither Company nor Dr. Berman will unreasonably withhold or delay
their consent to any proposed settlement.

      (h) Non-exclusivity. The right to indemnification and the payment of
expenses incurred in defending a Proceeding in advance of its final disposition
conferred in this Paragraph 12 shall not be exclusive of any other right which
Dr. Berman may have or hereafter may acquire under any statute or certificate of
incorporation or by-laws of Company or any subsidiary, agreement, vote of
shareholders or disinterested directors or trustees or otherwise.

                                       10
<PAGE>

13.   Assignment

      This Agreement is personal in nature, and neither this Agreement nor any
part of any obligation herein shall be assignable by Dr. Berman. Company shall
be entitled to assign this Agreement, upon the prior approval of Dr. Berman, to
any affiliate of Company that assumes the ownership and control of the business
of Company provided, however that Company shall remain secondarily liable to Dr.
Berman.

14.   Severability

      Should any term, provision, covenant or condition of this Agreement be
held to be void or invalid, the same shall not affect any other term, provision,
covenant or condition of this Agreement, but such remainder shall continue in
full force and effect as though each such voided term, provision, covenant or
condition is not contained herein.

15.   Governing Law and Submission to Jurisdiction

      This Agreement shall be governed by and construed in accordance with the
laws of the State of California applicable to contracts made and to be carried
out in California. Each of the parties submits to the exclusive jurisdiction of
any state or federal court sitting in Los Angeles, California in any action or
proceeding arising out of or relating to this Agreement and further agrees that
all claims in respect of the action or proceeding may be heard and determined in
any such court and agrees not to bring any action or proceeding arising out of
or relating to this Agreement in any other court. Each of the parties agrees
that a final judgment in any action or proceeding so brought shall be conclusive
and may be enforced by suit on the judgment or in any other manner so provided
by law.

16.   Attorney's Fees

      In the event that any party shall bring an action or proceeding in
connection with the performance, breach or interpretation of this Agreement,
then the prevailing party in any such action or proceeding, as determined by the
court or other body having jurisdiction, shall be entitled to recover from the
losing party all reasonable costs and expenses of such action or proceeding,
including reasonable attorneys' fees, court costs, costs of investigation,
expert witness fees and other costs reasonably related to such action or
proceeding.

17.   Binding Agreement

      This Agreement shall be binding upon the parties, and each party's
successors and assigns.

18.   Captions

      The Paragraph captions herein are inserted only as a matter of convenience
and reference and in no way define, limit or describe the scope of this
Agreement or the intent of any provisions hereof.

                                       11
<PAGE>

19.   Notice

      All notices and other communications under this Agreement shall be in
writing and mailed, telegraphed, telecopied, or delivered by hand (by a party or
a recognized courier service) to the other party at the following address (or to
such other address as such party may have specified by notice given to the other
party pursuant to this provision):

                  If to Company:
                  Berman Center, LLC
                  211 E. Ontario
                  Suite 800
                  Chicago, IL  60611

                  -----------------

                  If to Dr. Berman:

                  c/o Kirkpatrick & Lockhart Nicholson Graham LLP
                  10100 Santa Monica Boulevard
                  7th Floor
                  Los Angeles, CA  90067
                  Attn: Jeryl A. Bowers, Esq.

                  With Courtesy Copies of all notices to Dr. Berman
                  simultaneously sent to the following:

                  Manatt, Phelps & Phillips, LLP
                  11355 West Olympic Boulevard
                  Los Angeles, CA  90064
                  Attn:  Roger L. Armstrong, Esq.

          ///

          ///

          ///

          ///

          ///

          ///

          ///

          ///

                                       12
<PAGE>

20.   Entire Agreement

      This Agreement contains the entire agreement of the parties relating to
the subject matter hereof, and the parties hereto have made no agreements,
representations or warranties relating to the subject matter of this Agreement
that are not set forth otherwise herein. In this regard, each of the parties
represents and warrants to the other party that such party is not relying on any
promises or representations that do not appear in writing herein. This Agreement
supersedes all prior agreements, whether written or oral, pertaining hereto.
Each of the parties further agrees and understands that this Agreement can be
amended or modified only by a written agreement signed by all parties.

                           [SIGNATURE PAGE TO FOLLOW]

                                       13
<PAGE>

      IN WITNESS WHEREOF, this Agreement is executed as of the day and year
first above written.

                                       BERMAN CENTER, INC., a Delaware
                                       corporation

                                       By: /s/ SAMUEL CHAPMAN
                                           -------------------------------------
                                           Name:  Samuel Chapman
                                           Title:  Chief Executive Officer

                                       and

                                       LAURA A.C. BERMAN, LCSW, PH.D.

                                       By: /s/ LAURA BERMAN
                                           -------------------------------------
                                           Laura A.C. Berman, LCSW, Ph.D.

                                       14EXHIBIT 10.2

                              THE BERMAN CENTER LLC
                            PLACEMENT AGENT AGREEMENT

                                                     Dated as of: April 11, 2005

Hunter World Markets, Inc.
9300 Wilshire Boulevard
Penthouse Suite
Beverly Hills, CA 90212

Ladies and Gentlemen:

      The undersigned, The Berman Center LLC (the "Company"), hereby agrees with
Hunter World Markets, Inc. ("Hunter") as follows:

      1.    Placement.

      The Company hereby engages Hunter to act as its exclusive  placement agent
in a transaction on a "best  efforts"  basis  involving the issuance and sale by
the Company  (the  "Offering")  of Units,  each Unit  consisting  of (i) two (2)
shares of Common  Stock;  (ii) one  three-year  warrant to purchase one share of
Common  Stock at an  exercise  price equal to $1.05 (200% of the issue price per
share - the  "Issue  Price")  (a "Class A  Warrant");  and (iii) one  three-year
warrant to  purchase  one share of Common  Stock at an  exercise  price equal to
$1.575 (300% of Issue Price) per share (a "Class B Warrant"). The price per Unit
shall be  $1.05.  Prior to and as a  condition  to the  initial  closing  of the
Offering  and  the  reverse  merger  (the  "Merger")  of  the  Company  with  an
over-the-counter  Bulletin  Board  listed shell  company  (the  "Shell") (i) the
Company shall reorganized as a C corporation and (ii) there shall be outstanding
13,050,000 shares of the Company's Common Stock.

      The Class A Warrants shall be redeemable by the Company at a price of five
(5) cents per  warrant  in the  event  (i)  there is an  effective  registration
statement  covering the shares of Common Stock  underlying  the Class A Warrants
and (ii) the closing market price of shares of Common Stock listed on a national
securities  market equals or exceeds  $1.575 which is 300% of the Issue Price of
the shares of Common Stock issued further to the Private Placement Unit Offering
for twenty of the thirty  consecutive  trading days  immediately  preceding  the
Company's notice of redemption.

      The Class B Warrants shall be redeemable by the Company at a price of five
(5) cents per  warrant  in the  event  (i)  there is an  effective  registration
statement  covering the shares of Common Stock  underlying  the Class B Warrants
and (ii) the closing market price of shares of Common Stock listed on a national
securities  market  equals or exceeds $2.10 which is 400% of the Issue Price for
twenty  of  the  thirty  consecutive  trading  days  immediately  preceding  the
Company's notice of redemption.

                                       1
<PAGE>

      The  "Minimum  Funding"  shall be  $3,000,000  (2,857,142  Units)  and the
"Maximum Funding" shall be $6,000,000  (5,714,284 Units). This pricing assumes a
capitalization of approximately  15,000,000 issued and outstanding shares (after
giving  effect  to  the  Merger)  for a  pre-money  valuation  of  approximately
$8,000,000.

      The Company shall file an SB-2 registration statement no later than thirty
(30) days  following  the closing of the Merger.  The Company  will use its best
efforts to have it declared  effective 180 days after the initial closing of the
Offering.  The securities to be included in the SB-2 registration  statement are
the Common Stock purchased as part of the Units, the Class A Warrants, the Class
B Warrants,  the Placement  Agent Warrants (as that term is defined  herein) and
the Bridge Warrants (as that term is defined herein). No additional shares shall
be included unless the Company shall have first received  Hunter's prior written
consent so long as all  securities  purchased  by  investors in the Offering are
included in the Form SB-2.

      The Company has borrowed an aggregate of $400,000 from funds introduced to
the Company by Hunter (the "Bridge Notes"). In connection therewith, the Company
issued such funds  warrants  (the "Bridge  Warrants")  to purchase up to 134,786
Membership  Interests in the Company at a per LLC  Membership  Interest price of
$0.9348156  (after the  recapitalization  of the  Company  into a C  corporation
referenced  above,  the Bridge  Warrants  will  represent  the right to purchase
400,000  shares of the Company's  Common Stock at a per share  exercise price of
$0.315).

      All  monies  raised in the  Offering  shall be  placed  in a  non-interest
bearing escrow account until the Minimum Funding amount is raised and deposited.

      Upon  closing of the  Minimum  Funding  amount,  proceeds  shall  first be
applied to payoff any interest and principal outstanding under the Bridge Notes.

      Hunter  shall not be  obligated  to sell any Units  and this  Offering  by
Hunter shall be solely on a "best efforts basis."

      The initial closing of Minimum Funding will take place concurrent with the
execution of a reverse  merger  agreement  covering the Merger and the filing of
14C Information  Statement  covering the Merger by the Shell with the Securities
and Exchange Commission or at such earlier time as mutually agreed in writing by
the parties.  Any  additional  monies  raised under this Offering must be raised
within  thirty (30) days after the  initial  Closing.  The initial  term of this
Agreement  shall be for a period of six months  from the date of this  Agreement
unless  terminated  sooner by the mutual  written  agreement  of the Company and
Hunter.  The period  commencing  on the date of execution of this  Agreement and
ending six months hereafter is referred to herein as the "Placement Term."

                                       2
<PAGE>

      As a condition of the initial closing of the Minimum Funding,  the Company
will provide  Hunter with: (a) an employment  agreement  between the Company and
Laura Berman that is reasonably  acceptable to Hunter,  (b) evidence that all of
the media  companies,  media  projects  (including but not limited to books) and
related  interests  owned or controlled by Laura Berman are owned by the Company
and (c) a signed non-compete  agreement with Laura Berman reasonably  acceptable
to Hunter.

      The Company shall prepare a Private Placement  Memorandum  ("PPM"),  which
shall not contain a  materially  misleading  statement,  or omit to state a fact
required to make the statement  therein not  misleading.  The Offering  shall be
conducted  pursuant to Regulation D promulgated  by the  Securities and Exchange
Commission  (the  "SEC")  and  shall be  offered  and sold  only to  "Accredited
Investors"  as that term is defined in Regulation D. The Offering is intended to
qualify as a Regulation D, Rule 506  transaction.  Other than Hunter itself,  no
person,  party or  entity,  including  the  Company,  its  officers,  directors,
employees, agents, or attorneys, may distribute the Private Placement Memorandum
used in  connection  with the  offering of the Units,  in any manner  (including
electronically) to any party, without the prior written consent of Hunter.

      2.    Public Company Status

      Concurrent  with the initial  closing of the  Offering,  the Company  will
complete  the  Merger  with  Shell  provided  by Hunter  and/or  its  affiliates
provided,  however  that such  Shell  shall be subject  to the  approval  of the
Company  and its legal  counsel.  In  connection  with the  Merger  (but  before
issuance of the Units under the  Offering),  the  existing  shareholders  of the
Company  will receive 87% of the issued and  outstanding  shares of stock of the
post merger company and the existing  holders of the Shell, and their designees,
will hold the  remaining  13% of the issued and  outstanding  shares of the post
merger company.

      3.    Compensation.

      As compensation for the Units sold directly by Hunter, Hunter will receive
the following:  (i) 10% commission on the total gross proceeds raised by Hunter;
(ii) a non-accountable  expense allowance in the amount of 2% of the total gross
proceeds  raised by Hunter;  and (iii) warrants to purchase  common stock in the
Company  equal to 10% of the  Common  Stock  included  in any units  sold in the
Offering (from Hunter and Company),  provided,  however,  that Hunter has raised
the Minimum Funding amount ("Placement Agent Warrants").

      The Placement Agent Warrants will receive registration rights identical to
the rights granted to the holders of Class A Warrants and Class B Warrants.  The
Placement  Agent Warrants will be exercisable at the Issue Price and will have a
three (3) year term.

                                       3
<PAGE>

      4.    Exclusivity.

            (a)   During the  Placement  Term,  Hunter shall have the  exclusive
right to raise $6,000,000 (the "Exclusive Funding Amount").

            (b)   All  monies  raised  by  the  Company  or  Hunter  during  the
Placement Term shall be under the same terms and conditions as the Offering.

            (c)   The Company may not  solicit,  engage or continue to work with
any underwriters, third party finders, brokers, or other consultants, during the
Placement Term, without express written approval of Hunter. During the Placement
Term,  the  Company  shall  provide  Hunter  with the name and  other  pertinent
information on any potential investor before accepting such investment,  however
the Company shall at all times retain sole discretion to accept such investment.

            (d)   Hunter may raise up to the Maximum Funding amount prior to the
Company  delivering notice of any potential  investor,  in which case,  Hunter's
investors shall be accepted and the Offering will be closed.

      5.    Right of First  Refusal.  Provided  that Hunter is able to raise the
Minimum Funding amount during the Placement Term, Hunter shall have the right of
first refusal (the "Right of First  Refusal") for any equity  financing  entered
into by the  Company  within  12  months  from  the  date of the  filing  of the
registration  statement for the securities  issued further to the Offering.  The
Right of First Refusal shall not apply to (i) any  strategic  partner  financing
whereby an investor brings qualitative value in addition to money being invested
or (ii) any financing related to an acquisition transaction.

      6.    Reserved.

      7.    Break Up Fee.

            (a)   In the  event  the  Company  receives,  after  the date of the
reverse  merger  agreement to be entered into between the Company and the Shell,
an  unsolicited  proposal  or offer  from a person or entity,  or any  affiliate
thereof to acquire all or substantially all of the assets or outstanding  equity
of the Company (an  "Acquisition  Proposal"),  and the Board of Directors of the
Company determines in good faith that its fiduciary obligations under applicable
law require that such  Acquisition  Proposal be accepted,  the Company shall pay
the Shell the sum of $100,000 as liquidated damages.

                                       4
<PAGE>

            (b)   Hunter may reasonably  determine that based upon due diligence
or market  conditions,  it may be  impractical  to raise  money for the  Company
during the Placement Term. In such an event, the parties will be discharged from
liability under this Break Up Fee provision.

      8.    Representations, Warranties and Covenants of Hunter.

            Hunter represents, warrants and covenants as follows:

            (a)   Hunter has the  necessary  power to enter into this  Agreement
and to consummate the transactions contemplated hereby.

            (b)   The execution and delivery by Hunter of this Agreement and the
consummation  of the  transactions  contemplated  herein  will not result in any
violation  of, or be in  conflict  with,  or  constitute  a default  under,  any
agreement  or  instrument  to which  Hunter is a party or by which Hunter or its
properties are bound, or any judgment,  decree, order or, to Hunter's knowledge,
any statute,  rule or regulation  applicable  to Hunter.  This  Agreement,  when
executed and delivered by Hunter,  will constitute the legal,  valid and binding
obligations of Hunter,  enforceable in accordance with their  respective  terms,
except  to the  extent  that (i) the  enforceability  hereof or  thereof  may be
limited by bankruptcy,  insolvency,  reorganization,  moratorium or similar laws
from time to time in effect and  affecting  the rights of  creditors  generally,
(ii) the  enforceability  hereof or thereof is subject to general  principles of
equity, or (iii) the indemnification provisions hereof or thereof may be held to
violate public policy.

            (c)   Hunter will not deliver any documents  related to the Offering
to any person it does not reasonably believe to be an Accredited  Investor based
upon documentary evidence thereof, where appropriate.

            (d)   Hunter  will  not  intentionally   take  any  action  that  it
reasonably  believes  would cause the Offering to violate the  provisions of the
Securities  Act of 1933,  the  Securities  Exchange Act of 1934,  the respective
rules and regulations  promulgated  thereunder (the "Rules and  Regulations") or
applicable "Blue Sky" laws of any state or jurisdiction.

            (e)   Hunter  shall use all  reasonable  efforts  to  determine  (i)
whether the Investor is an  Accredited  Investor  and (ii) that any  information
furnished by the Investor is true and accurate.  Hunter shall have no obligation
to insure  that any check,  note,  draft or other means of payment for the Units
will be honored, paid or enforceable against the Investor in accordance with its
terms.

            (f)   Hunter  is a  member  of  the  NASD,  and  is a  broker-dealer
registered  as such  under  the  Securities  Exchange  Act of 1934 and under the
securities  laws of the  states in which the Units  will be  offered  or sold by
Hunter,  unless an exemption for such state registration is available to Hunter.
Hunter is in compliance  with all material rules and  regulations  applicable to
Hunter generally and applicable to Hunter's participation in the Offering.

                                       5
<PAGE>

      9.    Representations and Warranties of the Company.

            The Company represents and warrants as follows:

            (a)   The execution,  delivery and performance of this Agreement has
been or will be duly and validly  authorized by the Company and will be, a valid
and  binding  agreement  of the  Company,  enforceable  in  accordance  with its
respective  terms,  except to the extent that (i) the  enforceability  hereof or
thereof may be limited by bankruptcy, insolvency, reorganization,  moratorium or
similar laws from time to time in effect and  affecting  the rights of creditors
generally,  (ii) the  enforceability  hereof or  thereof  is  subject to general
principles of equity or (iii) the  indemnification  provisions hereof or thereof
may be held to violate  public policy.  The securities to be issued  pursuant to
the  transactions  contemplated by this Agreement have been duly authorized and,
when  issued  and paid for in  accordance  with (x) this  Agreement  and (y) the
certificates/instruments representing such securities, will be valid and binding
obligations  of the Company,  enforceable  in accordance  with their  respective
terms,  except to the extent that (1) the enforceability  thereof may be limited
by bankruptcy, insolvency, reorganization,  moratorium or similar laws from time
to time in effect and  affecting  the  rights of  creditors  generally,  (2) the
enforceability  thereof is subject to general principles of equity, or (iii) the
indemnification  provisions  hereof or  thereof  may be held to  violate  public
policy.  All  corporate  action  required  to be  taken  for the  authorization,
issuance  and sale of the  securities  has been  duly and  validly  taken by the
Company.

            (b)   The outstanding limited liability  membership interests of the
Company  have been duly  authorized  and issued and the Company has  outstanding
capitalization as will be set forth in the PPM. The Company is not a party to or
bound by any  instrument,  agreement or other  arrangement  providing  for it to
issue any capital stock, rights, warrants,  options or other securities,  except
for this Agreement,  the agreements described herein or as set forth in the PPM.
All issued and outstanding  securities of the Company, have been duly authorized
and validly issued and are fully paid and  non-assessable;  the holders  thereof
have no rights of rescission or preemptive  rights with respect  thereto and are
not subject to personal  liability  solely by reason of being security  holders;
and none of such securities was issued in violation of the preemptive  rights of
any holders of any security of the Company.

            (c)   The Common Stock being  offered as part of the Units,  as well
as issuable  upon  exercise of the Warrants  that form part of the Units will be
duly  authorized and when issued and paid for in accordance  with this Agreement
and   proper    exercise    of   such    warrants,    respectively,    and   the
certificates/instruments representing such Common Stock, will be validly issued,
fully-paid  and  non-assessable;  the  holders  thereof  will not be  subject to
personal  liability solely by reason of being such holders;  such securities are
not and will not be  subject  to the  preemptive  rights  of any  holder  of any
security of the Company.

                                       6
<PAGE>

            (d)   The  Company  has good and  marketable  title to, or valid and
enforceable  leasehold  estates  in,  all  items of real and  personal  property
necessary to conduct its business  (including,  without  limitation  any real or
personal property to be owned or leased by the Company).

            (e)   There is no litigation or governmental  proceeding pending or,
to the best of the Company's  knowledge,  threatened  against,  or involving the
properties or business of the Company.

            (f)   The  Company  is  not  aware  of  any  federal  or  securities
violations by any of its current  officers,  directors or consultants,  nor does
the Company  believe that any of its officers,  directors or consultants  are or
were the  subject of any  enforcement  proceedings  by the  Securities  Exchange
Commission or the National Association of Securities Dealers.

            (g)   The Company has been duly organized and is validly existing as
a limited  liability  company  in good  standing  under the laws of the State of
Illinois.  The Company  does not own or  control,  directly  or  indirectly,  an
interest in any other  corporation,  partnership,  trust, joint venture or other
business entity.  The Company is duly qualified or licensed and in good standing
as a foreign  corporation  in each  jurisdiction  in which the  character of its
operations  requires  such  qualification  or licensing  and where failure to so
qualify would have a material adverse effect on the Company. The Company has all
requisite  power and authority,  and all material and necessary  authorizations,
approvals,   orders,  licenses,   certificates  and  permits  of  and  from  all
governmental  regulatory  officials and bodies (domestic and foreign) to conduct
its  business  (and  proposed  business),  and the Company is doing  business in
strict compliance with all such  authorizations,  approvals,  orders,  licenses,
certificates and permits and all foreign,  federal,  state and local laws, rules
and regulations  concerning the business in which it is engaged. The Company has
all  power  and  authority  to enter  into  this  Agreement,  to  carry  out the
provisions and conditions  hereof, and all consents,  authorizations,  approvals
and orders  required in  connection  herewith  have been  obtained.  No consent,
authorization or order of, and no filing with, any court,  government  agency or
other body is required by the Company for the issuance of the securities  except
for applicable federal and state securities laws. The Company, in the last three
years,  has not  incurred  any  liability  arising  under or as a result  of the
application  of  any of  the  provisions  of the  Securities  Act of  1933,  the
Securities Exchange Act of 1934 or the Rules and Regulations.

            (h)   The Company is not in breach of, or in default under, any term
or provision of any material  indenture,  mortgage,  deed of trust, lease, note,
loan  or  credit  agreement  or  any  other  material  agreement  or  instrument
evidencing an obligation for borrowed money, or any other material  agreement or
instrument to which it is a party or by which it or any of its properties may be
bound or  affected.  The Company is not in  violation  of any  provision  of its
charter or by-laws  (other than the  obligation  to hold annual  meetings of its
shareholders  and related  matters) or in violation of any  franchise,  license,
permit,  judgment,  decree or order,  or in violation  of any  statute,  rule or
regulation.  Neither  the  execution  and  delivery of this  Agreement,  nor the

                                       7
<PAGE>

issuance and sale or delivery of the securities,  nor the consummation of any of
the transactions contemplated herein, has conflicted with or will conflict with,
or has  resulted  in or  will  result  in a  breach  of,  any of the  terms  and
provisions  of, or has  constituted or will  constitute a default under,  or has
resulted in or will result in the creation or imposition of any lien,  charge or
encumbrance  upon any property or assets of the Company or pursuant to the terms
of any indenture, mortgage, deed of trust, note, loan or credit agreement or any
other  agreement or instrument  evidencing an obligation for borrowed  money, or
any other  agreement or instrument to which the Company may be bound or to which
any of the  property or assets of the  Company is subject  except (a) where such
default, lien, charge or encumbrance would not have a material adverse effect on
the  Company  and (b) nor  will  such  action  result  in any  violation  of the
provisions  of the charter or the by-laws of the  Company or,  assuming  the due
performance by Hunter of its  obligations  hereunder,  any statute or any order,
rule or  regulation  applicable  to the Company of any court or of any  foreign,
federal,  state or other  regulatory  authority or other  government body having
jurisdiction over the Company.

            (i)   The  information in the PPM,  including,  without  limitation,
information  concerning any liability or obligation,  direct or contingent,  for
borrowed  money,  or any  transaction  other  than  in the  ordinary  course  of
business, or with respect to the declaration or payment of any dividend or other
distribution  on or in respect of its  capital  stock and as to any  outstanding
obligations to any officer or director of the Company, shall be true and correct
as of the date of the PPM,  and the PPM shall be amended  during  the  Placement
Term to update any changes in the information therein.

            (j)   There are no claims for  services  in the nature of a finder's
or  origination  fee with  respect to the sale of the Units,  or the  securities
comprising  a  part   thereof,   or  any  other   arrangements,   agreements  or
understandings that may affect Hunter's compensation.

            (k)   The Company owns or possesses,  free and clear of all liens or
encumbrances  and rights  thereto or therein  by third  parties,  the  requisite
licenses  or other  rights to use all  trademarks,  service  marks,  copyrights,
service names, trade names, patents,  patent applications and licenses necessary
to conduct its business and to the best of the Company's  knowledge  there is no
claim  or  action  by any  person  pertaining  to,  or  proceeding,  pending  or
threatened, which challenges the exclusive rights of the Company with respect to
any trademarks,  service marks, copyrights, service names, trade names, patents,
patent applications and licenses used in the conduct of the Company's businesses
except any claim or action that would not have a material  adverse effect on the
Company; to the best of the Company's knowledge, the Company's current products,
services  or  processes  do not  infringe  or will not  infringe  on the patents
currently held by any third party.

            (l)   The Company is not under any  obligation  to pay  royalties or
fees of any kind  whatsoever to any third party with respect to any  trademarks,
service  marks,   copyrights,   service  names,  trade  names,  patents,  patent
applications,  licenses or technology it has developed, uses, employs or intends
to use or employ, other than to their respective licensors.

                                       8
<PAGE>

            (m)   Subject  to the  performance  by  Hunter  of  its  obligations
hereunder,  the offer and sale of the Units comply, and will continue to comply,
up to the Placement Term in all material  respects with the requirements of Rule
506 of Regulation D  promulgated  by the SEC pursuant to the  Securities  Act of
1933 and any other  applicable  federal and state laws,  rules,  regulations and
executive  orders.  The Company will not cause or knowingly permit any action to
be taken in connection  with the placement  which violates the Securities Act of
1933 or any state securities laws.

            (n)   All taxes which are due and payable from the Company have been
paid in full  and the  Company  does  not  have  any  tax  deficiency  or  claim
outstanding assessed or proposed against it.

            (o)   None of the Company nor to the best of the Company's knowledge
any of its officers, directors, employees or agents, nor any other person acting
on behalf of the Company,  has, directly or indirectly,  given or agreed to give
any money,  gift or similar  benefit  (other  than legal  price  concessions  to
customers  in the  ordinary  course  of  business)  to any  customer,  supplier,
employee  or agent of a customer  or  supplier,  or  official or employee of any
governmental  agency or instrumentality of any government  (domestic or foreign)
or any political  party or candidate  for office  (domestic or foreign) or other
person who is or may be in a  position  to help or hinder  the  business  of the
Company (or assist it in  connection  with any actual or  proposed  transaction)
which (i) might  subject  the  Company  to any  damage or  penalty in any civil,
criminal or governmental  litigation or proceeding,  or (ii) if not given in the
past,  might have had a  materially  adverse  effect on the assets,  business or
operations  of the Company as reflected in any of the financial  statements,  or
(iii) if not  continued  in the  future,  might  adversely  affect  the  assets,
business, operations or prospects of the Company in the future.

            (p)   All  information  and  statements  provided  by the Company to
prospective investors will be true and correct.

            (q)   Any written offering material prepared by the Company will not
be  misleading  or  violative of the  anti-fraud  provisions  of the  Securities
Exchange Act of 1934.

            (r)   The financial  statements  presented to Hunter fairly  reflect
the  financial  condition of the Company and the results of its  operations at a
time and for the periods covered by the financial statements.

      10.   Certain Covenants and Agreements of the Company.

            The  Company  covenants  and agrees at its  expense  and without any
expense to Hunter as follows:

                                       9
<PAGE>

            (a)   To  advise  Hunter  of  any  material  adverse  change  in the
Company's  financial  condition,  prospects  or business  or of any  development
materially  affecting the Company or rendering untrue or misleading any material
statement in the PPM  occurring at any time prior to any closing of any Units as
soon as the Company is either informed or becomes aware thereof.

            (b)   The  Company  shall  at  all  times  have  sufficient   shares
authorized  and unissued to keep  available out of its  authorized  Common Stock
solely for the purpose of issuance  upon the exercise of all Warrants  described
in this  Agreement,  such  number of shares  of  Common  Stock as shall  then be
issuable upon the exercise or conversion thereof.

            (c)   To ensure that any transactions  between or among the Company,
or any of its officers, directors and affiliates be on terms and conditions that
are no less favorable to the Company,  than the terms and conditions  that would
be available in an "arm's length" transaction with an independent third party.

            (d)   To  cooperate  with  Hunter as to permit  the  Offering  to be
conducted  in  a  manner  consistent  with  the  applicable  state  and  federal
securities.

            (e)   To provide its financial  statements  from  inception  through
December 31, 2004.

            (f)   To not cause or  knowingly  permit  any  action to be taken in
connection  with the placement  which violates the Securities Act of 1933 or any
State securities laws.

      11.   Indemnification.

            (a)   The  Company  hereby  agrees that it will  indemnify  and hold
Hunter  and  each   officer,   director,   shareholder,   employee,   attorneys,
accountants,  agents or representative of Hunter,  and each person  controlling,
controlled by or under common  control with Hunter within the meaning of Section
15 of the Securities Act of 1933 or Section 20 of the Securities Exchange Act of
1934 or the SEC's rules and regulations  promulgated  thereunder (the "Rules and
Regulations"),  harmless  from and  against  any and all  loss,  claim,  damage,
liability,  cost or expense whatsoever  (including,  but not limited to, any and
all  reasonable  legal fees and other  expenses  and  disbursements  incurred in
connection with investigating, preparing to defend or defending any action, suit
or proceeding, including any inquiry or investigation,  commenced or threatened,
or any claim whatsoever or in appearing or preparing for appearance as a witness
in any action,  suit or  proceeding,  including  any inquiry,  investigation  or
pretrial proceeding such as a deposition  including attorneys' fees in the event
of a  breach  of this  representation  and  warranty)  to which  Hunter  or such
indemnified  person of Hunter may become  subject  under the  Securities  Act of
1933, the Securities  Exchange Act of 1934,  the Rules and  Regulations,  or any
other federal or state law or regulation,  common law or otherwise,  arising out
of or based  upon (i) any untrue  statement  or alleged  untrue  statement  of a
material fact contained in (a) this Agreement, (b) any written offering material

                                       10
<PAGE>

prepared  by the Company  including  the PPM (except  those  written  statements
relating to Hunter given by an indemnified  person for inclusion  therein),  (c)
any  application  or other  document  or written  communication  executed by the
Company or based upon written information  furnished by the Company filed in any
jurisdiction  in order to qualify the Units,  the Common  Stock and the Warrants
under the securities laws thereof, or any state securities commission or agency;
(ii) the omission or alleged  omission from documents  described in clauses (a),
(b) or (c) above of a material fact  required to be stated  therein or necessary
to make the  statements  therein  not  misleading;  or (iii)  the  breach of any
representation,  warranty,  covenant  or  agreement  made by the Company in this
Agreement. The Company further agrees that upon demand by an indemnified person,
at any time or from time to time, it will promptly  reimburse  such  indemnified
person for any loss,  claim,  damage,  liability,  cost or expense  actually and
reasonably  paid  by  the  indemnified  person  as  to  which  the  Company  has
indemnified   such  person  pursuant  hereto.   Notwithstanding   the  foregoing
provisions  of this  Section  11(a),  any such payment or  reimbursement  by the
Company of fees, expenses or disbursements  incurred by an indemnified person in
any  proceeding in which a final  judgment by a court of competent  jurisdiction
(after all  appeals  or the  expiration  of time to  appeal) is entered  against
Hunter or such indemnified  person as a direct result of Hunter or such person's
gross negligence or willful misfeasance will be promptly repaid to the Company.

            (b)   Hunter  hereby  agrees  that it will  indemnify  and  hold the
Company and each officer, director,  shareholder,  employee or representative of
the Company, and each person controlling,  controlled by or under common control
with the Company  within the meaning of Section 15 of the Securities Act of 1933
or  Section  20 of  the  Securities  Exchange  Act of  1934  or  the  Rules  and
Regulations,  harmless  from  and  against  any and  all  loss,  claim,  damage,
liability,  cost or expense whatsoever  (including,  but not limited to, any and
all  reasonable  legal fees and other  expenses  and  disbursements  incurred in
connection with investigating, preparing to defend or defending any action, suit
or proceeding, including any inquiry or investigation,  commenced or threatened,
or any claim whatsoever or in appearing or preparing for appearance as a witness
in any action,  suit or  proceeding,  including  any inquiry,  investigation  or
pretrial  proceeding  such  as a  deposition)  to  which  the  Company  or  such
indemnified person of the Company may become subject under the Securities Act of
1933, the Securities  Exchange Act of 1934,  the Rules and  Regulations,  or any
other federal or state law or regulation,  common law or otherwise,  arising out
of or based  upon (i) the  conduct  of  Hunter  or its  officers,  employees  or
representatives in acting as placement agent for the Offering or (ii) the breach
of any  representation,  warranty,  covenant or agreement made by Hunter in this
Agreement.

            (c)   Promptly  after receipt by an  indemnified  party of notice of
commencement  of any action  covered by Section 11(a) or 11(b),  the party to be
indemnified shall,  within five (5) business days, notify the indemnifying party
of the commencement  thereof; the omission by one indemnified party to so notify
the  indemnifying  party  shall  not  relieve  the  indemnifying  party  of  its
obligation to indemnify any other  indemnified  party that has given such notice
and shall not relieve the  indemnifying  party of any liability  outside of this
indemnification  if not  materially  prejudiced  thereby.  In the event that any
action is brought against the indemnified  party, the indemnifying party will be

                                       11
<PAGE>

entitled to participate  therein and, to the extent it may desire, to assume and
control  the  defense  thereof  with  counsel  chosen by it which is  reasonably
acceptable to the indemnified party. After notice from the indemnifying party to
such  indemnified  party of its election to so assume the defense  thereof,  the
indemnifying  party  will not be liable to such  indemnified  party  under  such
Section 11(a) or 11(b) for any legal or other expenses  subsequently incurred by
such  indemnified  party  in  connection  with  the  defense  thereof,  but  the
indemnified  party  may,  at its own  expense,  participate  in such  defense by
counsel  chosen by it,  without,  however,  impairing the  indemnifying  party's
control  of  the  defense.   Subject  to  the  proviso  of  this   sentence  and
notwithstanding  any other  statement  to the  contrary  contained  herein,  the
indemnified  party or  parties  shall  have the right to choose its or their own
counsel  and  control  the  defense  of any  action,  all at the  expense of the
indemnifying  party if,  (i) the  employment  of such  counsel  shall  have been
authorized in writing by the  indemnifying  party in connection with the defense
of  such  action  at  the  expense  of  the  indemnifying  party,  or  (ii)  the
indemnifying  party shall not have employed counsel  reasonably  satisfactory to
such  indemnified  party to have charge of the  defense of such action  within a
reasonable  time  after  notice of  commencement  of the  action,  or (iii) such
indemnified  party or parties shall have reasonably  concluded that there may be
defenses available to it or them which are different from or additional to those
available  to one  or  all  of the  indemnifying  parties  (in  which  case  the
indemnifying  parties  shall not have the right to direct  the  defense  of such
action on behalf of the  indemnified  party or parties),  in any of which events
such  fees  and  expenses  of one  additional  counsel  shall  be  borne  by the
indemnifying party; provided, however, that the indemnifying party shall not, in
connection with any one action or separate but substantially  similar or related
actions in the same jurisdiction  arising out of the same general allegations or
circumstance,  be liable for the  reasonable  fees and expenses of more than one
separate  firm of attorneys  at any time for all such  indemnified  parties.  No
settlement of any action or  proceeding  against an  indemnified  party shall be
made without the consent of the indemnifying party.

            (d)   In order to provide  for just and  equitable  contribution  in
circumstances  in which the  indemnification  provided  for in Section  11(a) or
11(b) is due in accordance  with its terms but is for any reason held by a court
to be  unavailable  on grounds of policy or  otherwise,  the  Company and Hunter
shall  contribute  to the  aggregate  losses,  claims,  damages and  liabilities
(including  legal or other expenses  reasonably  incurred in connection with the
investigation  or defense of same) which the other may incur in such  proportion
so that Hunter shall be  responsible  for such percent of the  aggregate of such
losses,  claims,  damages and  liabilities  as shall equal the percentage of the
gross  proceeds  paid to Hunter and the  Company  shall be  responsible  for the
balance;   provided,    however,   that   no   person   guilty   of   fraudulent
misrepresentation  within the meaning of Section 11(f) of the  Securities Act of
1933 shall be  entitled  to  contribution  from any person who was not guilty of
such  fraudulent  misrepresentation.  For  purposes of this Section  11(d),  any
person  controlling,  controlled by or under common control with Hunter,  or any
partner,  director,  officer,  employee,  representative  or  any  agent  of any
thereof,  shall have the same rights to  contribution  as Hunter and each person
controlling,  controlled by or under common  control with the Company within the
meaning  of  Section  15 of the  Securities  Act of  1933 or  Section  20 of the
Securities  Exchange  Act of 1934  and  each  officer  of the  Company  and each

                                       12
<PAGE>

director  of the  Company  shall  have the same  rights to  contribution  as the
Company.  Any party  entitled to  contribution  will,  promptly after receipt of
notice of commencement of any action,  suit or proceeding  against such party in
respect of which a claim for  contribution  may be made  against the other party
under this  Section  11(d),  notify  such party  from whom  contribution  may be
sought,  but the  omission  to so notify  such party shall not relieve the party
from whom contribution may be sought from any obligation they may have hereunder
or otherwise if the party from whom contribution may be sought is not materially
prejudiced thereby. The indemnity and contribution  agreements contained in this
Section 11 shall remain operative and in full force and effect regardless of any
investigation  made by or on behalf of any indemnified person or any termination
of this Agreement.  Notwithstanding anything to the contrary in this Section 11,
no party shall be liable for contribution  with respect to the settlement of any
claim or action effected without its written consent.

      12.   Non-Circumvention.

            Pursuant to this  Agreement,  it is  contemplated  that Hunter shall
supply to the  Company and its  officers  and  directors  a certified  list (the
"Certified  List") of  investors  and  customers  that Hunter has  contacted  in
connection with the proposed  reverse merger  transaction and related  financing
transaction.  If, during the twelve month period after the placement  term,  the
Company  completes  a  Transaction  (as  defined  below)  with a  person  on the
Certified  List, the Company shall pay Hunter  concurrently  with the closing of
such Transaction the compensation due under Section 3 of this Agreement.

            "Transaction"  shall be  defined  as any  direct or  indirect  sale,
transfer, conveyance,  exchange, financing, investment, trade, exchange or other
change in legal or beneficial ownership of any property, whether accomplished by
an  issuance  or  purchase  of  assets  of  securities,  merger,  consolidation,
management contract, joint venture, partnership,  trade or exchange of assets or
stock or otherwise.

      13.   Payment of Expenses.

            The Company  hereby agrees to bear all of its expenses in connection
with the Offering,  including,  but not limited to the  following:  filing fees,
printing and duplicating costs, Company approved advertisements, road show costs
and expenses  (road show costs and expenses up to a maximum of $45,000 which the
parties  acknowledged  was paid  further to the  $400,000 of the Bridge  Notes),
postage  and  mailing  expenses  with  respect to the  transmission  of offering
materials,  registrar and transfer  agent fees,  escrow agent fees and expenses,
fees of the Company's  counsel (but  excluding  fees of counsel to the Placement
Agent in excess of the $10,000 paid further to the $400,000 of the Bridge Notes)
and accountants, issue and transfer taxes, if any.

                                       13
<PAGE>

      14.   Board of  Representation.  All  existing  members of the Shell shall
resign  on the  closing.  The  Investors  shall  have the  right  to  elect  one
additional member to the Board of Directors following the Merger for a period of
one year.

      15.   Lock-up.  All shares of The Berman  Center  LLC  publicly  issued in
connection with the reverse merger to existing shareholders of The Berman Center
LLC will  have  trading  and  transfer  restrictions  for a period  of 12 months
following the date of the filing of the registration statement.

      16.   Conditions of Each Closing.

            Each closing shall be held at the offices of Company's counsel or as
otherwise  determined  by Hunter  and the  Company.  The  obligations  of Hunter
hereunder shall be subject to the continuing accuracy of the representations and
warranties  of the Company  herein as of the date hereof and as of each  closing
date  with  respect  to the  Company  as if it had  been  made on and as of such
closing date;  the accuracy on and as of each closing date of the  statements of
the  officers of the Company made  pursuant to the  provisions  hereof;  and the
performance  by the  Company  on and as of each  closing  of its  covenants  and
obligations hereunder and to the following further conditions:

            (a)   At or prior to each  closing,  counsel  for Hunter  shall have
been furnished such documents,  certificates and opinions as they may reasonably
require  for the  purpose of  enabling  them to review or pass upon the  matters
referred to in this Agreement and the offering materials or in order to evidence
the  accuracy,  completeness  or  satisfaction  of any  of the  representations,
warranties or conditions herein contained.

            (b)   At and prior to each  closing,  (i) there  shall  have been no
material   adverse  change  in  the  condition  or  prospects  or  the  business
activities,  financial or otherwise,  of the Company from the latest dates as of
which such  condition is set forth in the offering  materials;  (ii) there shall
have been no transaction,  not in the ordinary course of business,  entered into
by the Company  which has not been  disclosed  in the  offering  materials or to
Hunter in writing;  (iii)  except as set forth in the  offering  materials,  the
Company shall not be in default under any provision of any  instrument  relating
to any  outstanding  indebtedness  for which a waiver or extension  has not been
otherwise  received;  (iv) except as set forth in the  offering  materials,  the
Company shall not have issued any  securities  (other than those to be issued as
provided in the offering materials) or declared or paid any dividend or made any
distribution of its capital stock of any class and there shall not have been any
change in the indebtedness (long or short term) or liabilities or obligations of
the Company  (contingent or otherwise);  (v) no material amount of the assets of
the Company  shall have been  pledged or  mortgaged,  except as indicated in the
offering materials; and (vi) no action, suit or proceeding, at law or in equity,
against the Company or affecting any of its  properties  or businesses  shall be
pending or  threatened  before or by any court or  federal or state  commission,
board  or  other  administrative  agency,   domestic  or  foreign,   wherein  an
unfavorable  decision,  ruling or finding could materially  adversely affect the
businesses, prospects or financial condition or income of the Company, except as
set forth in the offering materials.

                                       14
<PAGE>

            (c)   At each closing,  Hunter shall have received a certificate  of
the Company signed by its chief  executive  officer,  dated as of the applicable
closing date, to the effect that the  conditions set forth in  subparagraph  (b)
above have been  satisfied and that,  as of the  applicable  closing  date,  the
representations  and  warranties  of the Company  set forth  herein are true and
correct.

      17.   Miscellaneous.

            (a)   This Agreement may be executed in any number of  counterparts,
each of which shall be deemed to be an  original,  but all which shall be deemed
to be one and the same  instrument.  (b) Any notice  required or permitted to be
given  hereunder  shall be given in writing and shall be deemed  effective  when
deposited  in the United  States  mail,  postage  prepaid,  or when  received if
personally delivered or faxed, addressed as follows:

            To Hunter:

            Hunter World Markets, Inc.
            9300 Wilshire Boulevard
            Penthouse Suite
            Beverly Hills, CA 90212
            Attention: Todd Ficeto
            Telephone: (310) 286-2211
            Fax: (310) 286-2373

            with a copy to:

            Shustak Jalil & Heller
            400 Park Avenue
            New York, New York 10022
            Attention:  James P. Jalil, Esq.
            Telephone: (212) 688-5900
            Fax: (212) 688-6151

            To the Company:

            The Berman Center LLC
            211 East Ontario
            Suite 800
            Chicago, IL  60611
            Attention:  Samuel Chapman
            Telephone: 800-709-4709
            Facsimile:   312-255-8007

                                       15
<PAGE>

            with a copy to:

            Kirkpatrick & Lockhart, LLP
            10100 Santa Monica Blvd., Suite 700
            Los Angeles, CA  90067
            Attention:  Jeryl Bowers
            Telephone:  310-552-5000
            Fax:  310-552-5001

or to such other address of which written notice is given to the others.

            (c)   This Agreement shall be construed  pursuant to the laws of the
State of California without regard to conflicts of law principals  thereof.  Any
controversy arising hereunder shall be resolved by arbitration from the American
Arbitration Association.

            (d)   This Agreement  contain the entire  understanding  between the
parties  hereto  and may not be  modified  or amended  except by a writing  duly
signed by the party against whom enforcement of the modification or amendment is
sought.

            (e)   If any provision of this Agreement shall be held to be invalid
or unenforceable, such invalidity or unenforceability shall not affect any other
provision of this Agreement.

                                       16
<PAGE>

      IN WITNESS WHEREOF,  the parties hereto have executed this Agreement as of
the date first written above.

                                               THE BERMAN CENTER LLC

                                                /S/ SAMUEL CHAPMAN
                                               ---------------------------------
                                               By:  Samuel Chapman
                                               Its: Chief Executive Officer

AGREED AND ACCEPTED

HUNTER WORLD MARKETS, INC.

 /S/ TODD FICETO
--------------------------
By:  Todd Ficeto
Its: President and CEO

                                       17

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00086-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00086-of-00352.parquet"}]]